STRUCTURED ABSTRACT
Background Preeclampsia is a severe pregnancy complication that affects about 2-8% of pregnant women globally and is one of the leading causes of maternal and fetal mortality and morbidity. Telomere length change has been associated with aging, environmental stress, and various diseases. Studying the telomere length change in preeclampsia complicated placentas may shed light on the pathophysiology of preeclampsia.
Objectives In this study, we aimed to explore if associations exist between placental telomere length and preeclampsia, gestational age, and other demographic, clinical and physiological factors related to pregnancy.
Study Design We collected placentas samples from 120 severe preeclamptic deliveries and 129 healthy full-term deliveries in Hawaii between year 2006 and 2013 and measured the average absolute placental telomeres with quantitative polymerase chain reaction (qPCR). We retrieved their pre-recorded demographic, clinical and physiological data and conducted multiple linear regressions to associate placental telomeres with preeclampsia and other variables.
Results Placental telomere length of severe preeclampsia cases showed no significant difference (P=0.20) from healthy controls after controlling for gestational age difference. Instead, we identified that placental telomere length consistently decreases as gestation progresses (P=6.10e-05). Male babies have shorter placental telomere than female babies in the early trimester (p = 0.024), but the placentas of male babies have a reduced rate of telomere shortening along pregnancies, compared to those of female babies (p = 0.029). Latino mothers show longer placenta telomeres than other ethnicities (P=0.012), whereas mothers of blood type O have shorter placenta telomeres than those of other blood types (P=0.039).
Conclusions Using the largest multiethnic cohort to date, we showed the lack of association between preeclampsia and placental telomere length. Rather, gestational age is the most dominant variable associated with placental telomere shortening.
Condensation Placental telomere length shows no significant association with preeclampsia but significantly shortens with the progressing gestational age at different rates for male and female babies.
Why was this study conducted?
Understanding the TL change in healthy and preeclampsia complicated placenta may help us better understand the physio-pathological impact of preeclampsia.
What are the key findings?
We found no significant association between severe preeclampsia and placental TL in the largest multi-ethnic cohort to date.
Placental TL shortens consistently largely due to gestational age increase.
Placentas of male babies have shorter TLs at the early third trimester but slower TL shortening compared to those of female babies.
Latino mothers have longer placental TL compared to non-Latino mothers.
Mothers of blood type O have shorter placenta TL than others.
What does this study add to what is already known?
We showed that placental telomere length shortening is not associated with preeclampsia but the gestational age in a large multi-ethnical cohort.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (www.bd2k.nih.gov), P20 COBRE GM103457 awarded by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD to L.X. Garmire.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB #CHS23976 of Hawaiian Biorepository gave ethical approval of this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflict of Interest The authors declare no conflict of interest.
Role of the funding source. This research was supported by grants K01ES025434 awarded by NIEHS through funds provided by the trans-NIH Big Data to Knowledge (BD2K) initiative (www.bd2k.nih.gov), P20 COBRE GM103457 awarded by NIH/NIGMS, R01 LM012373 and R01 LM012907 awarded by NLM, and R01 HD084633 awarded by NICHD to L.X. Garmire.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
